Eli Lilly

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Eli Lilly 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About LLY

Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The firm's products consist of diabetes, oncology, immunology, neuroscience, and other products and therapies. 

CEO
David A. Ricks
CEODavid A. Ricks
Employees
47,000
Employees47,000
Headquarters
Indianapolis, Indiana
HeadquartersIndianapolis, Indiana
Founded
1876
Founded1876
Employees
47,000
Employees47,000

LLY Key Statistics

Market cap
693.26B
Market cap693.26B
Price-Earnings ratio
48.58
Price-Earnings ratio48.58
Dividend yield
0.76%
Dividend yield0.76%
Average volume
4.25M
Average volume4.25M
High today
$737.40
High today$737.40
Low today
$728.50
Low today$728.50
Open price
$732.32
Open price$732.32
Volume
2.55M
Volume2.55M
52 Week high
$969.65
52 Week high$969.65
52 Week low
$623.78
52 Week low$623.78

LLY News

Seeking Alpha 13h
Novo's Wegovy beats Lilly’s Zepbound in real-world study for heart diseases

Novo Nordisk (NVO) (OTCPK:NONOF) announced on Sunday that its popular weight loss drug Wegovy resulted in more than a 50% decrease in serious heart issues such...

Novo's Wegovy beats Lilly’s Zepbound in real-world study for heart diseases
TipRanks 2d
Oklo, KDP, CoreWeave, Eli Lilly, Canada Goose: Trending by Analysts

Analysts are intrested in these 5 stocks: ( (OKLO) ), ( (KDP) ), ( (CRWV) ), ( (LLY) ) and ( (GOOS) ). Here is a breakdown of their recent ratings and the ratio...

TipRanks 2d
Eli Lilly’s Promising Study on Mazdutide for Alcohol Use Disorder: A Financial Perspective

Eli Lilly And Company ((LLY)) announced an update on their ongoing clinical study. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50%...

Analyst ratings

79%

of 28 ratings
Buy
78.6%
Hold
21.4%
Sell
0%

More LLY News

TipRanks 2d
Eli Lilly’s Innovative Cancer Study: Exploring New Frontiers with TNG456 and Abemaciclib

Eli Lilly And Company ((LLY)) announced an update on their ongoing clinical study. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50%...

TipRanks 2d
Eli Lilly’s Olomorasib Study: A New Phase in Drug Optimization

Eli Lilly And Company ((LLY)) announced an update on their ongoing clinical study. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50%...

TipRanks 2d
Eli Lilly offers discounted deal on Mounjaro to UK pharmacies, BBC reports

Eli Lilly (LLY) has offered a discounted deal on weight loss drug Mounjaro to UK suppliers, which is expected to limit the price increase to consumers from Sept...

TipRanks 2d
Eli Lilly enters partnership with Chinese healthcare platform, Bloomberg says

Eli Lilly (LLY) has partnered with Chinese healthcare platform JD Health International to sell its drugs for obesity and diabetes online, Amber Tong of Bloomber...

Benzinga 3d
Eli Lilly technical analysis - Eli Lilly - Benzinga

...

Eli Lilly technical analysis - Eli Lilly - Benzinga
Benzinga 3d
Stock Of The Day: Another Breakout For Eli Lilly?

Zinger Key Points Buyer's remorse can cause resistance to form in market. Eli Lilly (LLY) stalls out at a former support level. Get Discounted Real-Time Trade...

Stock Of The Day: Another Breakout For Eli Lilly?
TipRanks 3d
Eli Lilly Temporarily Stops U.K. Shipments of Its Weight-Loss Drug

U.S. pharmaceutical giant Eli Lilly (LLY) has temporarily stopped shipments of its popular weight-loss drug to the United Kingdom (U.K.). Elevate Your Investing...

People also own

Based on the portfolios of people who own LLY. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.